This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Mammography World Markets

3.3.4 The Five-Year Relative Survival Ratio in Canada 41

3.3.5 Age-Standardized Incidence Rates of Ductal and Lobular Breast Cancer in Canada 42

3.4 Breast Cancer in the U.K. 42

3.4.1 Breast Cancer by Age in the U.K. 43

3.5 Breast Cancer Mortality in OECD Countries 44

3.5.1 Relative Survival Rates from Breast Cancer in OECD Countries 46

3.6 Breast Cancer in Australia 47

3.6.1 Incidence of Breast Cancer by Age in Australia 47

3.6.2 Projected Female Breast Cancer Diagnosis in Australia, 2020 49

3.6.3 Risk of Being Diagnosed with Breast Cancer in Australia 50

3.6.4 Most Common Types of Breast Cancers in Australia 50

3.6.5 Age at Diagnosis by Histological Type in Australia 51

3.6.6 Most Frequently Recorded Anatomical Location of Breast Cancer 51

3.6.7 Ductal Carcinoma In Situ in Australia 52

3.6.8 Incidence of DCIS by Age in Australian Women 53

3.6.9 Female Breast Cancer Mortality in Australia by Age 53

3.6.10 Projections of Female Breast Cancer Mortality in Australia 54

3.6.11 Survival after Diagnosis of Female Breast Cancer in Australia 55

3.6.12 Hospitalizations for Female Breast Cancer in Australia 55

3.7 Breast Cancer in East Asia 56

3.8 Breast Cancer in Western Asia 56

3.9 Breast Cancer Mortality in Korea 57

3.10 Age-Specific Incidence of Breast Cancer in Japan 58

3.11 Age-Specific Breast Cancer Rate in China 58

3.12 Breast Cancer in Young Asian Women 59

4. Emerging Technologies in Breast Imaging 604.1 The Gold Standard: Full-Field Digital Mammography 604.2 Tomosynthesis/3-D Mammography 624.3 Molecular Imaging 634.4 BSGI 63

3 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs